Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment.
Strand V, Sharp V, Koenig AS, Park G, Shi Y, Wang B, Zack DJ, Fiorentino D.
Ann Rheum Dis. 2012 Jan 17. [Epub ahead of print]
Related citations
Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis.
Dixon WG, Abrahamowicz M, Beauchamp ME, Ray DW, Bernatsky S, Suissa S, Sylvestre MP.
Ann Rheum Dis. 2012 Jan 12. [Epub ahead of print]
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.
Mercer LK, Green AC, Galloway JB, Davies R, Lunt M, Dixon WG, Watson KD; British Society for Rheumatology Biologics Register Control Centre Consortium, Symmons DP, Hyrich KL; on behalf of the British Society for Rheumatology Biologics Register.
Ann Rheum Dis. 2012 Jun;71(6):869-874. Epub 2012 Jan 12.
Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease.
Grader-Beck T, Boin F, von Gunten S, Smith D, Rosen A, Bochner BS.
Ann Rheum Dis. 2011 Dec;70(12):2218-24. Epub 2011 Aug 26.
Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI.
Gandjbakhch F, Foltz V, Mallet A, Bourgeois P, Fautrel B.
Ann Rheum Dis. 2011 Dec;70(12):2159-62. Epub 2011 Aug 22.
IgG4 multiorgan lymphoproliferative syndrome as a differential diagnosis of primary Sjogren's syndrome in men?
Nocturne G, Pavy S, Lazure T, Taoufik Y, Miceli C, Mariette X.
Ann Rheum Dis. 2011 Dec;70(12):2234-5. Epub 2011 Jun 6. No abstract available.
Serum β2 microglobulin correlates with the new ESSDAI in patients with Sjögren's syndrome.
Pertovaara M, Korpela M.
Ann Rheum Dis. 2011 Dec;70(12):2236-7. Epub 2011 May 30. No abstract available.
Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial.
Fleishaker DL, Garcia Meijide JA, Petrov A, Kohen MD, Wang X, Menon S, Stock TC, Mebus CA, Goodrich JM, Mayer HB, Zeiher BG.
Arthritis Res Ther. 2012 Jan 17;14(1):R11. [Epub ahead of print]
Identification and evaluation of novel synovial tissue biomarkers in rheumatoid arthritis by laser scanning cytometry.
Fueldner C, Mittag A, Knauer J, Biskop M, Hepp P, Scholz R, Wagner U, Sack U, Emmrich F, Tárnok A, Lehmann J.
Arthritis Res Ther. 2012 Jan 17;14(1):R8. [Epub ahead of print]
The detection of plasma levels of connective tissue growth factor in rheumatoid arthritis patients.
Fujishiro M, Yamaguchi A, Kawasaki M, Nozawa K, Takasaki Y, Takamori K, Ogawa H, Endo K, Ng PS, Takehara K, Sekigawa I.
Clin Exp Rheumatol. 2012 Jan-Feb;30(1):145-6. Epub 2012 Mar 7. No abstract available.
Six-transmembrane epithelial antigen of prostate 4 (STEAP4) is expressed on monocytes/neutrophils, and is regulated by TNF antagonist in patients with rheumatoid arthritis.
Tanaka Y, Matsumoto I, Iwanami K, Inoue A, Umeda N, Tanaka Y, Sugihara M, Hayashi T, Ito S, Sumida T.
Clin Exp Rheumatol. 2012 Jan-Feb;30(1):99-102. Epub 2012 Mar 6.
Melanoma and rheumatoid arthritis (brief report).
Perkins S, Cohen M, Rahme E, Bernatsky S.
Clin Rheumatol. 2012 Jun;31(6):1001-3. Epub 2012 Jan 13.
Risk factors for cardiovascular disease in rheumatoid arthritis.
Gabriel SE, Crowson CS.
Curr Opin Rheumatol. 2012 Mar;24(2):171-6.
The influence of individual joint impairment on functional disability in rheumatoid arthritis using a large observational database of Japanese patients.
Shidara K, Inoue E, Hoshi D, Tanaka E, Seto Y, Nakajima A, Momohara S, Taniguchi A, Yamanaka H.
J Rheumatol. 2012 Mar;39(3):476-80. Epub 2012 Jan 15.
Remission in early rheumatoid arthritis: predicting treatment response.
Ma MH, Ibrahim F, Walker D, Hassell A, Choy EH, Kiely PD, Williams R, Walsh DA, Young A, Scott DL.
J Rheumatol. 2012 Mar;39(3):470-5. Epub 2012 Jan 15.
Safety and efficacy of various dosages of ocrelizumab in Japanese patients with rheumatoid arthritis with an inadequate response to methotrexate therapy: a placebo-controlled double-blind parallel-group study.
Harigai M, Tanaka Y, Maisawa S; JA21963 Study Group.
J Rheumatol. 2012 Mar;39(3):486-95. Epub 2012 Jan 15.
IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis.
Troelsen LN, Jacobsen S, Abrahams JL, Royle L, Rudd PM, Narvestad E, Heegaard NH, Garred P.
J Rheumatol. 2012 Mar;39(3):463-9. Epub 2012 Jan 15.
Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortality.
Shourt CA, Crowson CS, Gabriel SE, Matteson EL.
J Rheumatol. 2012 Mar;39(3):481-5. Epub 2012 Jan 15.
Interferon-gamma induced nitric oxide-mediated apoptosis of anemia of chronic disease in rheumatoid arthritis.
Kheansaard W, Mas-Oo-di S, Nilganuwong S, Tanyong DI.
Rheumatol Int. 2012 Jan 19. [Epub ahead of print]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on